. 2019 Oct 24;49(5):1547–1554. doi: 10.3906/sag-1907-166

Table 4.

Univariate and multivariate survival analyses of stage III type II endometrial cancer patients according to age, NNMT, pAkt score, and p53 expression pattern.

			Univariate analysis		Multivariateanalysis
Parameter	Category	No. of cases	DSS		Hazard ratio(95% CI)
			No. of events	P		P
Age	<60	18	6	0.57			≥60	12	8
Age	NNMT	Low	11	0.57			3	0.039	4.9 (1.0-13.5)	0.046	High	19	11
pAkt	NNMT	Low	26	10	0.044	1.3 (0.9-3.4)	0.65	0.039	4.9 (1.0-13.5)	0.046
	High	4	4		0.044	1.3 (0.9-3.4)	0.65
p53	Normal	9	2	0.23
	Aberrant	15	9	0.23

DSS: Disease-specific survival, NNMT score: NNMT expression score in omental metastases of type II endometrial carcinoma, pAkt score: phospho-Akt expression score in omental metastases of type II endometrial carcinoma.